President Trump’s new executive order to slash US drug prices could trigger global price shifts, leaving Nigeria, heavily dependent on imports, vulnerable to medicine cost hikes and potential shortages.
- Trump’s policy mandates US pays the same price as the cheapest country globally.
- Over 70% of Nigeria’s medicines are imported, with limited local production.
- Aid-dependent programs like PEPFAR could also face indirect disruption.
Many Nigerians already struggle with high out-of-pocket healthcare costs. Any rise in drug prices may push essential medicines further out of reach for lower-income households, especially those relying on HIV, malaria, and TB treatments.
Will the Nigerian government intervene to protect citizens from rising drug costs, or will foreign policy shifts abroad further deepen local healthcare challenges?
